Results from a double-blind, placebo-controlled trial published in The New England Journal of Medicine revealed that children with Dravet syndrome, a severe form of epilepsy, had fewer seizures after taking a daily oral solution of the cannabis compound called cannabidiol, which does not have the psychoactive properties of marijuana. Show More Summary
There's a new clinical trial published in the New England Journal of Medicine showing a beneficial effect due to cannabidiol, a chemical isolated from marijuana, on drug-resistant seizures due to Dravet syndrome. Medical marijuana advocates are crowing, "I told you so!" As is usually the case, the real story is more nuanced.
The results of the trial, published this week in the New England Journal of Medicine, demonstrate that patients treated with a potential new medicine and antibody, called benralizumab, were more than four times likely to reduce their usage of oral corticosteroids than those taking a placebo.
(George Washington University) George Washington University researchers, published in the New England Journal of Medicine, find through looking at genetic data sets of presumed cancer-free women who carry BRCA 1/2 variants, the co-occurrence of a rare COMT genetic variant in some women. Show More Summary
Today, in the New England Journal of Medicine, the team from University Health Network in Toronto that developed the organization's protocol for medical assistance in dying (MAiD) describes UHN's approach and experience. This comes a year after Canada decriminalized medically assisted dying throughout the country.
Flushing fallopian tubes with a poppyseed oil-based solution may help a woman to conceive, according to a new study in the New England Journal of Medicine. Continue reading ? The post Can poppyseed oil help infertile couples conceive? appeared first on PBS NewsHour.
An article on conscientious objection in the New England Journal of Medicine has sparked outcry among conservative bioethicists. University of Pennsylvania bioethicists Ronit Y. Stahl and Ezekiel J. Emanuel argue that medical societies should “declare conscientious objection unethical” and remove conscience clauses from their codes of ethics. Show More Summary
The New England Journal of Medicine has a great piece on the arguments of the Partners Effect in the Eastern Massachusetts healthcare and hospital market. It is framed as an explainer as to why Lahey Clinic and Beth-Isreal-Deaconess would want to merge as a matter of public interest instead of internal gains seeking: The system […]
In patients experiencing a worsening of heart failure, the primary objective of treatment should be the patient-centric goal of symptom relief, says the author of an editorial in the current issue of the New England Journal of Medic...
One of Obamacare’s major architects, Ezekiel J. Emanuel, has just co-authored (with bioethicist Ronit Y. Stahl) a major attack on medical conscience in the New England Journal of Medicine. His position is that physicians must abandon...Show More Summary
EL PASO, Texas -- In a New England Journal of Medicine (NEJM) editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions. Show More Summary
(Texas Tech University Health Sciences Center El Paso) In a New England Journal of Medicine (NEJM) editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions. Show More Summary
Here’s what’s come in on Scott Gottlieb’s nomination as FDA Commissioner since my post last week. From the New England Journal of Medicine: a scathing commentary observes that “Gottlieb’s background places the agency, and the public, in a difficult position.” Two reasons: (1) “His previous experience in academic medicine, applied science, and government service is […]
(NEJM Group) The New England Journal of Medicine (NEJM) will host the 'Aligning Incentives for Sharing Clinical Trial Data' summit and live web event on April 3-4, 2017 in Boston, MA. The goal of the summit is to initiate an open and...Show More Summary
There was good news and bad news Friday for people at very high risk of heart attack or stroke. The good news: A study in the New England Journal of Medicine found the people taking a newer kind...
Three women suffering from a degenerative eye condition were blinded—likely permanently—in a clinical trial for stem cell therapy, according to a report published Wednesday in the New England Journal of Medicine. The women, who wereShow More Summary
(Oregon Health & Science University) Today the New England Journal of Medicine published results from a nearly 11-year follow-up study, that showed an estimated overall survival rate of 83.3 percent. According to the National Cancer Institute, prior to Gleevec's 2001 FDA approval, fewer than one in three CML patients survived five years past diagnosis.
This appeared at a New England Journal Of Medicine sub-site.Why Real-World Results Are So Challenging for Digital HealthArticle · February 8, 2017 Joseph C. Kvedar, MD & Alexander L. Fogel, MBA Partners HealthCare Stanford University...Show More Summary
Babies born at just 22 to 24 weeks of pregnancy continue to have sobering outlooks -- only about 1 in 3 survive. But according to a new study led by Duke Health and appearing Feb. 16 in the New England Journal of Medicine, those rates are showing small but measurable improvement. Show More Summary
Researchers are solving the issue of chronic underreporting of medical device adverse events. In the New England Journal of Medicine last month, they described their use of DELTA (Data Extraction and Longitudinal Analysis), a statistics software...Show More Summary